Showing 46,601 - 46,620 results of 226,405 for search '(( a ((a decrease) OR (linear decrease)) ) OR ( a ((greater decrease) OR (largest decrease)) ))', query time: 1.35s Refine Results
  1. 46601

    A model for the palliative effect of oral administration of BBG9-1 against RV gastroenteritis. by Tomohiro Kawahara (701841)

    Published 2017
    “…Mucosal protective factors coordinately protect against damage after RV infection to alleviate decreased gene expression of SGLT-1, which plays a pivotal role in water absorption. …”
  2. 46602

    Photographs of the left eye at the initial visit in a 36-year-old male patient with AZOOR. by Saho Saito (731215)

    Published 2015
    “…(C) Goldmann perimetry reveals a central scotoma of 80 × 70°. LogMAR value of the best-corrected visual acuity (BCVA) decreased to 2.0. …”
  3. 46603

    VPS4a expression in peripheral blood and heart tissue in patients with end-stage HF. by Neeta Adhikari (474583)

    Published 2014
    “…<p>(<b>A</b>) VPS4a transcript is higher in patients with end stage HF pre-LVAD (HF pre-LVAD) (n = 9) and is decreased 7 days post implant (HF 7 days post-LVAD) (n = 9) compared to age and gender matched controls (Control) (n = 6). …”
  4. 46604

    <i>Plasmodium</i> parasite killing in <i>An. culicifacies</i> (species A and species B). by Sonam Vijay (353683)

    Published 2013
    “…<p>(A) Melanized ookinetes (arrows) of <i>P. vivax</i> in sensitive <i>An. culicifacies</i> species A. …”
  5. 46605
  6. 46606

    Pythagorean Self-Awareness Intervention for Alcohol Relapse Prevention: A Randomized Pilot Controlled Trial by Christina Dimopoulou (20809053)

    Published 2025
    “…<p dir="ltr">In this randomized pilot controlled trial, we assessed the influence of PSAI on a variety of clinical outcomes, such as the prevention of alcohol relapse, the reduction of stress, and the enhancement of cognitive function. …”
  7. 46607

    Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    “…These values significantly decreased in the first postoperative year to 2.3 ± 2.6, 0.1 ± 0.3, 0.8 ± 1.6, 0, and 3.1 ± 2.8; in the second year to 2.1 ± 2.8, 0.4 ± 1.0, 0.0, 0.1 ± 0.3, and 2.6 ± 2.8; and in the third year to 2.0 ± 2.2, 0, 0.6 ± 1.7, 0.1 ± 0.3, and 2.8 ± 3.5 (Kruskal–Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g007" target="_blank">Fig 7</a>). …”
  8. 46608

    Levels of serum IL-17A and IL-17F in the AG, IG and control groups. by Zheng Zhou (152309)

    Published 2016
    “…Expression of serum IL-17A and IL-17F were significantly decreased in the AG and IG group compared with controls (P<0.001; respectively), whereas no significant difference was observed between the AG and IG groups (both P>0.05). …”
  9. 46609

    Base-case cost-effectiveness analysis with deterministic sensitivity analysis from a societal perspective. by May Ee Png (627594)

    Published 2014
    “…</p>†<p> Baseline+workdays lost at 3 days.</p>‡<p> Baseline+a ratio of 2.3 for direct cost of diabetic to non-diabetic medical care expense.…”
  10. 46610

    Example of the automated TSP maps in an ischemic stroke patient with a right-sided perfusion deficit. by Sunbin Song (4487854)

    Published 2017
    “…Voxels in healthy tissue demonstrate a signal intensity time-series that is like the average signal intensity time-series for all healthy tissue, while a voxel in the perfusion deficit will have a signal intensity time-series that is delayed, dispersed and/or decreased.…”
  11. 46611

    Induction of a Th1 CD4+ T-Cell Response in SLA-SE Immunized Animals. by Neal Van Hoeven (238795)

    Published 2016
    “…IFNγ+ CD4 T-cells were induced following immunization with WN-80E in combination with SLA-SE. At decreased antigen doses (100 ng/mouse), inclusion of SLA-SE resulted in a significant increase in cytokine positive cells relative to antigen only controls (p<0.005). …”
  12. 46612

    Telomestatin induces a de-localization of Topo III from TIN2 and TRF1. by Nassima Temime-Smaali (260017)

    Published 2009
    “…<p>Representative images are of untreated MRC5-V1/YFP-Topo III cells or cells treated for 48 h with 2 µM telomestatin. A, Topo III was detected by fluorescence of YFP-tagged Topo III (green) and TIN2 was detected by immunofluorescence (red). …”
  13. 46613

    Aβ42 binds to and impairs ABAD activity, while HA (human amylin) does not. by Yun-An Lim (337762)

    Published 2013
    “…<p>(A) Treatment of SH-SY5Y human neuroblastoma cells with Aβ42 causes decreased levels of estradiol, indicative of an impairment of ABAD activity, while HA does not. …”
  14. 46614

    Supplementary Material for: Type 1 Diastematomyelia Presenting in Adulthood; a Case Report of an Atypical Presentation by figshare admin karger (2628495)

    Published 2025
    “…In this case report, we present a rare case of an adult presenting with symptoms of lower back pain, urinary incontinence, and decreased sensation in the perineum secondary to diastematomyelia. …”
  15. 46615

    Table 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.docx by Yazhao Mei (13041882)

    Published 2025
    “…This prospective cohort study evaluated the 12-month efficacy and safety of denosumab in OI patients, with a historical control study with alendronate.</p>Materials and methods<p>Eight pediatric patients (1 mg/kg every 3 months; ≤60 mg/dose) and ten adults (60 mg every 6 months) received denosumab. …”
  16. 46616

    Table_2_Telomere length and the risk of cardiovascular diseases: A Mendelian randomization study.docx by Yingjian Deng (13999767)

    Published 2022
    “…</p>Materials and methods<p>In this two-sample MR study, we identified 154 independent TL-associated genetic variants from a genome-wide association study (GWAS) consisting of 472,174 individuals (aged 40–69) in the UK Biobank. …”
  17. 46617

    Image 1_Denosumab in patients with osteogenesis imperfecta and a historical control study with alendronate.tif by Yazhao Mei (13041882)

    Published 2025
    “…This prospective cohort study evaluated the 12-month efficacy and safety of denosumab in OI patients, with a historical control study with alendronate.</p>Materials and methods<p>Eight pediatric patients (1 mg/kg every 3 months; ≤60 mg/dose) and ten adults (60 mg every 6 months) received denosumab. …”
  18. 46618

    Pharmacological blockade of GABA<sub>A</sub> receptor inhibits neurite outgrowth of NPC SVZ. by Nadia Estefanía Gutierrez-Castañeda (18874528)

    Published 2024
    “…The left shift of the taurine + PTX–treated cells (blue line) mirrors the decreased number of neurite intersections when GABA<sub>A</sub> receptors were blocked (control <i>n</i> = 34 cells; taurine <i>n</i> = 38 cells; taurine + PTX <i>n</i> = 27 DCX+ cells). …”
  19. 46619

    Longitudinal fasting blood glucose patterns and arterial stiffness risk in a population without diabetes by Yuntao Wu (37012)

    Published 2017
    “…After adjustment for potential confounders, individuals with elevated-stable pattern had a 42.6 cm/s (95%CI: 24.7 to 60.6 cm/s) higher brachial-ankle pulse wave velocity level and a 37% (OR 1.37, 95%CI: 1.14 to 1.66) higher arterial stiffness risk, and individuals with moderate-increasing pattern had a 19.6 cm/s (95%CI: 6.9 to 32.3 cm/s) higher brachial-ankle pulse wave velocity level and a 17% (OR 1.17, 95%CI: 1.03 to 1.33) higher arterial stiffness risk, related to individuals with moderate-stable pattern. …”
  20. 46620

    Demonstration of robustness and tunability of our text-based hedonometer, and reasoning for choice of a specific metric. by Peter Sheridan Dodds (188891)

    Published 2011
    “…Lastly, in plot <b>F</b> (which uses plot <b>A</b>'s legend), we show how coverage of words decreases with word rank. …”